SigFormer: an Attention-Based Framework for Robust Single-Sample Mutational Signature Decomposition

preprint OA: closed
Full text JSON View at publisher
AI-generated summary by claude@2026-07, 2026-07-14

SigFormer is a transformer framework that uses cross-attention to robustly decompose mutational signatures in single cancer samples, outperforming existing methods, especially in noisy or overcomplete scenarios.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-14 · read from full text

The paper presents SigFormer, a set-conditioned transformer with cross-attention designed to decompose somatic mutational signatures from single samples, particularly under low mutation burden, high sampling noise, and large redundant candidate catalogs. Using PCAWG genomes and low-burden normal-tissue datasets (including clonal expansion and microdissection studies), SigFormer improves exposure recovery and detection accuracy versus likelihood-driven refitting (MuSiCal), preserves major tissue-level structure, and sensitively captures cooccurrence of low-abundance signatures without tumor-type–specific gating. It also quantifies an explicit unattributable residual component to avoid forced allocation when the catalogue is incomplete. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Somatic mutational signatures imprint the history of exogenous exposures and endogenous processes on the genome, offering critical insights into pathologic etiology and disease risk. However, accurate signature decomposition at the single-sample level is still challenging when mutation burden is low, sampling noise is high, and candidate catalogs are large and redundant. Here, we present SigFormer, a set-conditioned transformer framework designed to facilitate robust somatic mutation analysis without reliance on large cohorts. By leveraging a cross-attention mechanism between customized reference input and sample mutation profile, SigFormer improves exposure recovery and detection accuracy compared with likelihood-driven refitting (MuSiCal) with the largest performance gains in high-noise and overcomplete settings. On PCAWG genomes, SigFormer preserves major tissue-level structure while sensitively and accurately capturing cooccurrence of low-abundance signatures but without the need for tumor-type–specific gating. In low-burden normal-tissue datasets spanning clonal expansion and microdissection studies, SigFormer maintains the high accuracy and recovers stable tissue-dependent patterns of SBS1/SBS5/SBS40a, pointing to underlying tissue-specific mutagenic heterogeneity in normal tissues. Finally, SigFormer quantifies an explicit unattributable residual component when the catalogue is incomplete, preventing forced allocation into flexible flat signatures and providing a useful signal for downstream analyses.
Full text 1,685 characters · extracted from oa-doi-fallback · click to expand
Abstract Somatic mutational signatures imprint the history of exogenous exposures and endogenous processes on the genome, offering critical insights into pathologic etiology and disease risk. However, accurate signature decomposition at the single-sample level is still challenging when mutation burden is low, sampling noise is high, and candidate catalogs are large and redundant. Here, we present SigFormer, a set-conditioned transformer framework designed to facilitate robust somatic mutation analysis without reliance on large cohorts. By leveraging a cross-attention mechanism between customized reference input and sample mutation profile, SigFormer improves exposure recovery and detection accuracy compared with likelihood-driven refitting (MuSiCal) with the largest performance gains in high-noise and overcomplete settings. On PCAWG genomes, SigFormer preserves major tissue-level structure while sensitively and accurately capturing cooccurrence of low-abundance signatures but without the need for tumor-type–specific gating. In low-burden normal-tissue datasets spanning clonal expansion and microdissection studies, SigFormer maintains the high accuracy and recovers stable tissue-dependent patterns of SBS1/SBS5/SBS40a, pointing to underlying tissue-specific mutagenic heterogeneity in normal tissues. Finally, SigFormer quantifies an explicit unattributable residual component when the catalogue is incomplete, preventing forced allocation into flexible flat signatures and providing a useful signal for downstream analyses. Competing Interest Statement C.Z. is co-founders and equity holders of Pioneer Genomics Inc. The other authors declare no competing interests.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00